NR4A1 and aneurysmal bone cyst: Furthermore, 55.6% of hormone receptor-positive patients received at least one line of endocrine therapy before starting chemotherapy for aBC, while 89.5% of hormone receptor-negative (i.e., TNBC) patients received first-line chemotherapy (Supplementary Table 1).